Zhejiang Int'l Group Co

Zhejiang Int'l Group Co Debt / Assets

The Debt-to-Assets Ratio of Zhejiang Int'l Group Co (000411.SZ) as of Oct 22, 2026 is 0.01. In the previous year, Debt-to-Assets Ratio was 0.16 — a change of -91.15% (lower).

Debt / Assets

0.01

YoY

-91.15%

Last updated:

Debt-to-Assets Ratio of Zhejiang Int'l Group Co is 2025 0.01 . Debt-to-Assets Ratio of Zhejiang Int'l Group Co was 2024 0.16 . It decreases by -91.15% lower compared to the previous year.

The Zhejiang Int'l Group Co Debt / Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt / Assets
Date
Debt / Assets
Jan 1, 2018
0.26 CNY
Jan 1, 2019
0.21 CNY
Jan 1, 2020
0.23 CNY
Jan 1, 2021
0.22 CNY
Jan 1, 2022
0.15 CNY
Jan 1, 2023
0.18 CNY
Jan 1, 2024
0.16 CNY
Jan 1, 2025
0.01 CNY
The Zhejiang Int'l Group Co Debt / Assets history
YEARDebt / AssetsYoY
0.01-91.15%
0.16-11.95%
0.18+21.60%
0.15-32.88%
0.22-3.59%
0.23+9.38%
0.21-18.27%
0.26+2.63%
0.25+115.23%
0.12-38.37%
0.19+13.90%
0.17—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zhejiang Int'l Group Co Stock analysis

What does Zhejiang Int'l Group Co do? Zhejiang Int'l Group Co., Ltd. generates revenue by wholesaling and retailing pharmaceuticals and medical devices. The company buys products from pharmaceutical manufacturers or suppliers and distributes them to distributors, medical institutions, and pharmacies. It also sells directly to consumers through retail terminals. The firm operates exclusively within Mainland China, serving a broad customer base across the healthcare sector. The business model relies on purchasing products from manufacturers or suppliers, then reselling them through wholesale channels to medical institutions and pharmacies, or via retail terminals to end consumers. This dual-channel approach allows the company to reach both institutional and individual customers without direct manufacturing involvement. Mainland China represents the sole market for all its operations. Zhejiang Int'l Group Co., Ltd. focuses on pharmaceutical and medical device distribution, targeting distributors, medical institutions, and pharmacies as key wholesale clients. Retail sales are directed toward consumers through its own retail terminals. The company does not engage in manufacturing, instead acting as a middleman between producers and end users within the Chinese healthcare market. Zhejiang Int'l Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zhejiang Int'l Group Co stock

Debt-to-Assets Ratio of Zhejiang Int'l Group Co is 0.01 in 2025.

Debt-to-Assets Ratio of Zhejiang Int'l Group Co changed from 0.16 to 0.01, representing a -91.15% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt-to-Assets Ratio Zhejiang Int'l Group Co since 2006 – with annual values, charts, and detailed analysis.

The Debt-to-Assets ratio measures what percentage of a company's assets are financed through debt. Higher ratios indicate greater financial risk.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt-to-Assets Ratio's Zhejiang Int'l Group Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Zhejiang Int'l Group Co

All Key Metrics — Zhejiang Int'l Group Co